MCRB Jan 2026 1.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:11AM EDT. Market open.
Loading interactive chart...
- Simply Wall St.
Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
Seres Therapeutics ( NASDAQ:MCRB ) First Quarter 2024 Results Key Financial Results Net loss: US$40.1m (loss narrowed...
- GuruFocus.com
Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Unveiling key financial results and strategic directions, including the impactful launch of VOWST and promising developments in SER-155.
- GuruFocus.com
Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
Financial Highlights and Strategic Updates
© 2024 Yahoo. All rights reserved.